ReviewCureus2023

Efficacy of SGLT2 Inhibitors Versus Pioglitazone in the Treatment of Non-alcoholic Fatty Liver Disease or Non-alcoholic Steatohepatitis: A Systematic Review.

Simran Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.